Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Hua Medicine (Shanghai) Ltd. HUMDF

Full chart Compare
Set alert

Price alert · HUMDF

All alert types
0.30 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.3072 Day range 0.3072
0.2935 52-week range 0.50
YTD
-26.08%
1 year
-26.08%

Financial health

Altman Z-Score

-1.62 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 3

Valuation

P/E 2.6×
FY 2016: -10.2×FY 2017: -12.5×FY 2018: -0.3×FY 2019: -7.7×FY 2020: -8.0×FY 2021: -13.1×FY 2022: -14.8×FY 2023: -14.5×FY 2024: -4.4×FY 2025: 2.6×
FY 2016 5y median -13.1× FY 2025
P/S 5.9×
FY 2016: 6137×FY 2017: 325×FY 2018: 135×FY 2019: 147×FY 2020: 358×FY 2021: 0.0×FY 2022: 170×FY 2023: 40.7×FY 2024: 4.2×FY 2025: 5.9×
FY 2016 5y median 5.9× FY 2025
P/B 2.8×
FY 2016: -5.4×FY 2017: -3.6×FY 2018: 0.9×FY 2019: 3.1×FY 2020: 4.2×FY 2021: 9.5×FY 2022: 10.7×FY 2023: 30.8×FY 2024: -7.9×FY 2025: 2.8×
FY 2016 5y median 9.5× FY 2025
P/FCF -47.5×
FY 2016: -47.6×FY 2017: -17.0×FY 2018: -4.5×FY 2019: -9.3×FY 2020: -66.5×FY 2021: -12.5×FY 2022: -11.6×FY 2023: 3.5×FY 2024: -2.5×FY 2025: -47.5×
FY 2016 5y median -11.6× FY 2025
EV/EBITDA -18.8×
FY 2016: -46.2×FY 2017: -30.2×FY 2018: 0.6×FY 2019: -5.2×FY 2020: -6.6×FY 2021: -12.6×FY 2022: -15.5×FY 2023: -10.9×FY 2024: -1.1×FY 2025: -18.8×
FY 2016 5y median -12.6× FY 2025
EV/Sales 4.3×
FY 2016: 7251×FY 2017: 417×FY 2018: -23.3×FY 2019: 102×FY 2020: 248×FY 2021: 0.0×FY 2022: 148×FY 2023: 23.9×FY 2024: 0.9×FY 2025: 4.3×
FY 2016 5y median 4.3× FY 2025
FCF Yield -2.1%
FY 2016: -2.1%FY 2017: -5.9%FY 2018: -22.3%FY 2019: -10.7%FY 2020: -1.5%FY 2021: -8.0%FY 2022: -8.6%FY 2023: 28.2%FY 2024: -39.3%FY 2025: -2.1%
FY 2016 5y median -8.0% FY 2025

Profitability

Gross Margin 56.9%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: 43.7%FY 2023: 48.8%FY 2024: 48.7%FY 2025: 56.9%
FY 2016 5y median 48.7% FY 2025
Operating Margin -29.4%
FY 2016: -15825.0%FY 2017: -1387.6%FY 2018: -4373.4%FY 2019: -1898.9%FY 2020: -4067.2%FY 2021: 0.0%FY 2022: -1517.8%FY 2023: -377.4%FY 2024: -137.8%FY 2025: -29.4%
FY 2016 5y median -137.8% FY 2025
Net Margin 224.4%
FY 2016: -60727.4%FY 2017: -2593.6%FY 2018: -39464.6%FY 2019: -1922.5%FY 2020: -4575.6%FY 2021: 0.0%FY 2022: -1157.8%FY 2023: -275.7%FY 2024: -97.8%FY 2025: 224.4%
FY 2016 5y median -97.8% FY 2025
ROE 107.0%
FY 2016: 53.9%FY 2017: 28.6%FY 2018: -256.7%FY 2019: -40.3%FY 2020: -54.1%FY 2021: -73.5%FY 2022: -72.9%FY 2023: -208.8%FY 2024: 184.7%FY 2025: 107.0%
FY 2016 5y median -72.9% FY 2025
ROIC -10.8%
FY 2016: -46.7%FY 2017: -72.0%FY 2018: -3.2%FY 2019: -36.5%FY 2020: -31.9%FY 2021: -39.5%FY 2022: -27.0%FY 2023: -19.1%FY 2024: -26.9%FY 2025: -10.8%
FY 2016 5y median -26.9% FY 2025
ROA 73.3%
FY 2016: -159.4%FY 2017: -111.0%FY 2018: -241.8%FY 2019: -34.1%FY 2020: -33.1%FY 2021: -36.6%FY 2022: -18.2%FY 2023: -12.2%FY 2024: -16.4%FY 2025: 73.3%
FY 2016 5y median -16.4% FY 2025

Growth (YoY)

Revenue 87.7%
FY 2016: 0.0%FY 2017: 1667.2%FY 2018: -13.2%FY 2019: 143.8%FY 2020: -61.1%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 335.3%FY 2024: 234.0%FY 2025: 87.7%
FY 2016 FY 2025
Operating Income 60.0%
FY 2016: 0.0%FY 2017: -55.0%FY 2018: -173.6%FY 2019: -5.9%FY 2020: 16.6%FY 2021: 9.0%FY 2022: 16.7%FY 2023: -8.2%FY 2024: -22.0%FY 2025: 60.0%
FY 2016 FY 2025
EPS (diluted) 540.0%
FY 2016: 0.0%FY 2017: 23.5%FY 2018: -3773.1%FY 2019: 95.5%FY 2020: 8.9%FY 2021: 17.1%FY 2022: 38.2%FY 2023: -4.8%FY 2024: -13.6%FY 2025: 540.0%
FY 2016 FY 2025
Free Cash Flow 85.8%
FY 2016: 0.0%FY 2017: -162.2%FY 2018: -36.5%FY 2019: -28.4%FY 2020: 86.8%FY 2021: -629.4%FY 2022: 24.2%FY 2023: 441.5%FY 2024: -148.0%FY 2025: 85.8%
FY 2016 FY 2025

Financial Health

Current Ratio 6.2×
FY 2016: 8.9×FY 2017: 5.4×FY 2018: 19.0×FY 2019: 10.3×FY 2020: 9.8×FY 2021: 6.6×FY 2022: 5.0×FY 2023: 6.2×FY 2024: 4.0×FY 2025: 6.2×
FY 2016 5y median 6.2× FY 2025
Quick Ratio 5.6×
FY 2016: 8.9×FY 2017: 5.4×FY 2018: 19.0×FY 2019: 10.3×FY 2020: 9.8×FY 2021: 6.6×FY 2022: 5.0×FY 2023: 6.0×FY 2024: 3.7×FY 2025: 5.6×
FY 2016 5y median 5.6× FY 2025
Debt / Equity 0.3×
FY 2016: -1.3×FY 2017: -1.2×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 1.7×FY 2024: -2.2×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 7.3×
FY 2016: -7.1×FY 2017: -6.7×FY 2018: 4.0×FY 2019: 2.3×FY 2020: 2.9×FY 2021: 2.1×FY 2022: 2.3×FY 2023: 7.7×FY 2024: 4.1×FY 2025: 7.3×
FY 2016 5y median 4.1× FY 2025
Interest Coverage -17.8×
FY 2016: -20.6×FY 2017: -49.3×FY 2018: -113×FY 2019: -466×FY 2020: -80.2×FY 2021: -81.1×FY 2022: -72.8×FY 2023: -36.6×FY 2024: -41.0×FY 2025: -17.8×
FY 2016 5y median -41.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31